EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Discontinuation rates and predictors of Medical Cannabis cessation for chronic musculoskeletal pain

Mohammad Khak, Sina Ramtin iD, Juliet Chung, Asif M Ilyas, Ari Greis

PLOS One · 2025

DOI: 10.1371/journal.pone.0329897 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Mohammad Khak und 4 weiteren Autor:innen. Beteiligte Einrichtung: Rothman Institute Foundation for Opioid Research & Education, Philadelphia, Pennsylvania, United States of America. Hauptthemen laut MEDLINE: Musculoskeletal Pain, Chronic Pain, Medical Marijuana. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Medical cannabis (MC) is increasingly used as a treatment for chronic musculoskeletal pain, but there is limited data on factors influencing its discontinuation. This study aims to investigate the rates of MC discontinuation and explore factors influencing it in patients with chronic musculoskeletal pain. A retrospective analysis was conducted on 78 patients certified for medical cannabis over a 2 year period. Patient demographics, pain origin, and Global Physical Health (GPH) and Global Mental Health (GMH) scores were collected before intervention. Discontinuation rates were measured at three-month and one-year follow-up. Statistical analyses, including Fisher’s Exact Test and two-sample t-tests, were performed to assess associations between variables and discontinuation. The overall discontinuation rate of MC use was 57.9% at one year, with 44.7% of patients discontinuing within the first three months. Older age was significantly associated with higher discontinuation rates. Pain origin categories did not significantly differ between those who discontinued and continued MC use, although a higher proportion of patients in the discontinued group reported low back pain. No significant differences were observed in baseline GPH and GMH scores between the two groups. This study demonstrates a high discontinuation rate of MC use in patients for chronic musculoskeletal pain. The absence of significant differences in pain origin or baseline health scores suggests that factors beyond pain location or general health may contribute to the decision to discontinue MC. Further research is needed to explore the long-term effects of MC on pain management and patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Musculoskeletal PainChronic PainMedical MarijuanaHumansMaleFemaleMiddle AgedAdultRetrospective StudiesAged

Substanzen

Medical Marijuana

Autor:innen und Institutionen

  • Rothman Institute Foundation for Opioid Research & Education, Philadelphia, Pennsylvania, United States of America.
  • Rothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America.
  • Drexel University College of Medicine, Philadelphia, Pennsylvania, United States of America.

ORCID-Profile: Sina Ramtin

Zitieren

APA

Khak, M., Ramtin, S., Chung, J., Ilyas, A. M., & Greis, A. (2025). Discontinuation rates and predictors of Medical Cannabis cessation for chronic musculoskeletal pain. PLOS One. https://doi.org/10.1371/journal.pone.0329897

Vancouver

Khak M, Ramtin S, Chung J, Ilyas AM, Greis A. Discontinuation rates and predictors of Medical Cannabis cessation for chronic musculoskeletal pain. PLOS One. 2025. doi:10.1371/journal.pone.0329897

BibTeX
@article{Khak2025,
  author = {Khak, Mohammad and Ramtin, Sina and Chung, Juliet and Ilyas, Asif M and Greis, Ari},
  title = {Discontinuation rates and predictors of Medical Cannabis cessation for chronic musculoskeletal pain},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0329897}
}
Kostenlos starten →